HK3 and nonpapillary renal cell carcinoma: In order to further verify the ability of HK3 as a tumor marker of ccRCC, we collected clinicopathological characteristics baseline in relation to HK3 mRNA expression status in 910 ccRCC patients from TCGA and FUSCC cohorts.